Glibenclamide / Metformin Sales, Price Analysis, & Sales Forecast – 2017 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Glibenclamide
/ Metformin Sales, Price Analysis, & Sales Forecast – 2017”

report to their offering.

Introducing the new research, Glibenclamide / Metformin Sales, Price
Analysis, & Sales Forecast – 2017.

Find out the sales of Glibenclamide / Metformin worldwide and by
countries in North America, Europe, Japan, BRIC, and Australia. Discover
the growth trends of Glibenclamide / Metformin by countries, and also
find out sales forecast until 2021.

The research also provides Glibenclamide / Metformin unit price by
countries. The sales and price data from this report is useful for
analyzing Glibenclamide / Metformin sales trends, sales forecast for
Glibenclamide / Metformin, brand planning, Glibenclamide / Metformin
generics trends, product positioning, strategic forecasts, BD&L,
competitive intelligence, pricing analysis, and price benchmarks.

Research Scope:

  • Product: Glibenclamide / Metformin
  • Country Scope: US, Germany, France, Italy, Spain, UK, Japan, Brazil,
    Russia, India, China, Canada, and Australia
  • Companies marketing Glibenclamide / Metformin and by brand name in
    major countries
  • Historic Glibenclamide / Metformin sales revenues ($mn) worldwide and
    by countries, sales trends
  • Glibenclamide / Metformin unit price by countries, trends, and
    benchmarks
  • Glibenclamide / Metformin sales forecast ($mn) worldwide and by
    countries

Benefits to the User

  • Identify companies marketing Glibenclamide / Metformin by major
    countries
  • Find out Glibenclamide / Metformin sales, growth, and sales forecast
    by major countries; Use it for your market planning – market
    assessments, market sizing, market shares, BD&L, product strategy,
    positioning, and competitive intelligence
  • Determine the price of Glibenclamide / Metformin in major markets; Use
    it to devise pricing strategies, estimate patient shares, develop
    patient forecast models, and estimate annual therapy costs
  • Derive unit sales of Glibenclamide / Metformin by countries using
    pricing and sales data; Use it for your market planning – market
    assessments, market sizing, market shares, BD&L, product strategy,
    positioning, and competitive intelligence

Key Topics Covered:

1. Glibenclamide / Metformin – Introduction

2. Glibenclamide / Metformin Sales Analysis

3. Glibenclamide / Metformin Sales by Countries

4. Glibenclamide / Metformin Price Analysis by Countries

5. Glibenclamide / Metformin Sales Forecast

6. Glibenclamide / Metformin Sales Forecast by Countries

7. Methodology

For more information about this report visit http://www.researchandmarkets.com/research/nnc9tl/glibenclamide

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Endocrine
and Metabolic Disorders Drugs
, Drugs
by Therapeutic Area